文献速递免疫规划妇幼与学校卫生

母体肺炎球菌疫苗接种对低收入地区婴儿肺炎球菌疾病影响的模型研究

Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings.
PubMed 文献 · Vaccine · 2022-06-03

本研究建立年龄结构房室数学模型,评估母体肺炎球菌疫苗接种对婴儿肺炎球菌疾病的影响。模型显示母体接种可预防<1月龄婴儿73%(范围49-88%)的病例和1-2月龄婴儿55%(范围36-66%)的病例,估计使5岁以下儿童侵袭性肺炎球菌病死亡减少17%。研究提示母体接种可能显著减轻婴儿肺炎球菌疾病负担,支持开展实地临床研究。

要点

  • 母体肺炎球菌疫苗接种可预防<1月龄婴儿73%(范围49-88%)的病例。
  • 母体接种可预防1-2月龄婴儿55%(范围36-66%)的病例。
  • 估计使5岁以下儿童侵袭性肺炎球菌病死亡减少17%。

核心结论

  • 本研究显示母体肺炎球菌疫苗接种有潜力显著减轻婴儿肺炎球菌疾病负担,支持开展适当的实地临床研究。

研究设计与样本

  • 研究建立年龄结构房室数学模型,评估母体肺炎球菌疫苗接种的影响。

主要发现

  • 模型显示母体肺炎球菌疫苗接种可预防<1月龄婴儿73%(范围49-88%)的病例。
  • 模型显示母体肺炎球菌疫苗接种可预防1-2月龄婴儿55%(范围36-66%)的病例。
  • 估计使5岁以下儿童侵袭性肺炎球菌病死亡减少17%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出该策略的临床 trial 数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pneumococcal disease is a leading cause of mortality in young children. The largest burden of pneumococcal disease is in the first six months of life before protection from a complete schedule of direct immunisation is possible. Maternal pneumococcal vaccination has been proposed as a strategy for protection in this period of early childhood; however, limited clinical trial data exists. In this study, we developed an age-structured compartmental mathematical model to estimate the impact of maternal pneumococcal vaccination. Our model demonstrates how maternal pneumococcal vaccination could prevent 73% (range 49-88%) of cases in those aged <1 month and 55% (range 36-66%) in those 1-2 months old. This translates to an estimated 17% reduction in deaths due to invasive pneumococcal disease in children under five. Overall, this study demonstrates the potential for maternal pneumococcal vaccination to meaningfully reduce the burden of infant pneumococcal disease, supporting the case for appropriate field-based clinical studies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bilgin GM, Lokuge K, Glass K, et al. Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings. Vaccine. 2022. PMID: 35667913. doi:10.1016/j.vaccine.2022.05.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。